论文部分内容阅读
在坦桑尼亚,1982年报告了第一例抗氯 喹疟疾,现在抗性疟几乎遍及全国。抗疟药的大量应用是疟疾产生抗性的常见原因,用量不足在其发生和扩散上亦起一定的作用。在达累斯萨拉姆的研究表明,提前结束治疗系因氯喹有副作用,而用量不足则可能是由于自服药物。在坦桑尼亚,疟疾是发热的主要原因,疟疾病人自我诊断和治疗亦较普遍。因此,1991年在达累斯萨拉姆,对自服药物以及化学预防和治疗的抗疟药类型进行了调查。
In Tanzania, the first case of chloroquine malaria was reported in 1982 and now almost all of the country is resistant to malaria. The large number of applications of anti-malarial drugs is a common cause of malaria resistance, lack of dosage in its occurrence and proliferation also play a role. Studies in Dar-es-Salaam have shown that early termination of treatment is due to the side effects of chloroquine, which may be due to self-administered medications. In Tanzania, malaria is the main cause of fever and malaria patients are also self-diagnosed and treated more commonly. Thus, in Dar es Salaam in 1991, the types of anti-malarial drugs used for self-care and for chemical prevention and treatment were investigated.